Key points are not available for this paper at this time.
This review summarizes recent advances in bioresponsive Gd( iii ) contrast agents, particularly those developed between 2019 and 2024. Three major types of probe that respond specifically to changes in pH, chemicals, and enzymes have been highlighted.
Liu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: